Abrilada Interactions
There are 552 drugs known to interact with Abrilada (adalimumab), along with 8 disease interactions. Of the total drug interactions, 300 are major, 243 are moderate, and 9 are minor.
- View all 552 medications that may interact with Abrilada
- View Abrilada disease interactions (8)
Most frequently checked interactions
View interaction reports for Abrilada (adalimumab) and the medicines listed below.
- abacavir / lamivudine
- amitriptyline
- amlodipine
- amoxicillin
- apixaban
- Benadryl (diphenhydramine)
- Betaderm (betamethasone topical)
- bupropion
- celecoxib
- Centrum Silver (multivitamin with minerals)
- cephalexin
- cetirizine
- clonazepam
- clonidine
- conjugated estrogens
- Cymbalta (duloxetine)
- Cytomel (liothyronine)
- dapagliflozin
- duloxetine
- eletriptan
- Eliquis (apixaban)
- escitalopram
- fluoxetine
- Folate Forte (multivitamin)
- lamotrigine
- methotrexate
- Mirena (levonorgestrel)
- prednisone
- pregabalin
- trazodone
Abrilada disease interactions
There are 8 disease interactions with Abrilada (adalimumab) which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
Report options
QR code containing a link to this page
More about Abrilada (adalimumab)
- Abrilada consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
